Literature DB >> 21461914

Familial Barrett's esophagus: clues to genetic risks for esophageal adenocarcinoma.

Joel H Rubenstein.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21461914     DOI: 10.1007/s10620-011-1676-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

Review 2.  Genomewide association studies and assessment of the risk of disease.

Authors:  Teri A Manolio
Journal:  N Engl J Med       Date:  2010-07-08       Impact factor: 91.245

3.  High risk of malignancy in familial Barrett's esophagus: presentation of one family.

Authors:  Vicente Munitiz; Pascual Parrilla; Angeles Ortiz; Luisa F Martinez-de-Haro; Jose Yelamos; Joaquin Molina
Journal:  J Clin Gastroenterol       Date:  2008-08       Impact factor: 3.062

4.  Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.

Authors:  Rihong Zhai; Feng Chen; Geoffrey Liu; Li Su; Matthew H Kulke; Kofi Asomaning; Xihong Lin; Rebecca S Heist; Norman S Nishioka; Chau-Chyun Sheu; John C Wain; David C Christiani
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

5.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

6.  Familial Barrett's esophagus associated with adenocarcinoma.

Authors:  V J Jochem; P A Fuerst; J J Fromkes
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

7.  A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence.

Authors:  Adrian R McElholm; Amy-Jane McKnight; Chris C Patterson; Brian T Johnston; Laura J Hardie; Liam J Murray
Journal:  Gastroenterology       Date:  2010-04-24       Impact factor: 22.682

8.  The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.

Authors:  Erica di Martino; Laura J Hardie; Christopher P Wild; Yun Y Gong; Joanna R Olliver; Martin D Gough; Nigel C Bird
Journal:  Genet Med       Date:  2007-06       Impact factor: 8.822

9.  Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.

Authors:  James Doecke; Zhen Zhen Zhao; Nirmala Pandeya; Shahram Sadeghi; Mitchell Stark; Adèle C Green; Nicholas K Hayward; Penelope M Webb; David C Whiteman
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

10.  Familial gastroesophageal reflux and development of Barrett's esophagus.

Authors:  D W Crabb; M A Berk; T R Hall; P M Conneally; A A Biegel; G A Lehman
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

View more
  1 in total

1.  Barrett's esophagus in the patients with familial adenomatous polyposis.

Authors:  Zoran Gatalica; Mingkui Chen; Carrie Snyder; Sumeet Mittal; Henry T Lynch
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.